Folfox protocol
(2S)-2-[[4-[(2-amino-5-formyl-4-oxo-3,6,7,8-tetrahydropteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid;5-fluoro-1H-pyrimidine-2,4-dione;oxalic acid;platinum(2+);trans-(1R,2R)-1,2-dimethanidylcyclohexane
Molecular Identity
Folfox protocol
(2S)-2-[[4-[(2-amino-5-formyl-4-oxo-3,6,7,8-tetrahydropteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid;5-fluoro-1H-pyrimidine-2,4-dione;oxalic acid;platinum(2+);trans-(1R,2R)-1,2-dimethanidylcyclohexane
PubChem CID: 135659064
2D Structure
Properties
C34H42FN9O13Pt
Molecular Formula
998.80
Molecular Weight
g/mol
998.2534
Exact Mass
Da
348
TPSA
May have limited oral absorption
11
H-Bond Donors
19
H-Bond Acceptors
1290
Complexity
SMILES
Canonical SMILES
SMILES: Synonyms(11)
Folfox protocolFolfox regimenFOLFOX-4 protocolFOLFOX-6 protocolFOLFOX-7 protocolFolfoxFOLFOX-4FOLFOX-6FOLFOX-7C410216000Fluorouracil regimen with leucovorin calcium and oxaliplatin
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to Folfox protocol
Loading drug network...